Merck's COVID-19 pill cuts risk of death by 50% | CredoWeb

Artículo

Merck's COVID-19 pill cuts risk of death by 50%

Merck's COVID-19 pill cuts risk of death by 50%

Esta publicación es para usuarios registrados

Please register or log in with your account to read the full publication.

Molnupiravir COVID_19 oral drug

Compartir:

Comentarios

Ver otras publicaciones de este autor

Inorganic nitrate improves safety of coronary angiography in patients at renal injury risk

Intravascular imaging associated with improved outcomes compared with angiography

Ver todas las publicaciones del autor